Trial | Date trial author contacted | Date trial author replied | Date trial author was asked for additional information (short summary) | Date trial author provided data (short summary) |
Atabek 2008 | 24 January 2014 15 May 2014 |
No | 24 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details about the trial including funding, allocation concealment, randomisation method, dropout rates and adverse events |
N/A |
Berkowitz 2003 | 20 January 2014 15 May 2014 |
No | 20 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details about the trial including randomisation method, allocation concealment and adverse events |
N/A |
Berkowitz 2006 | 20 January 2014 15 May 2014 |
No | 20 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details on the trial's adverse events |
N/A |
Chanoine 2005 | 20 January 2014 25 March 2014 15 May 2014 |
20 January 2014 25 March 2014 15 May 2014 03/06/2014 |
20 January 2014 ‐ asked for additional unpublished data and other ongoing trials 25 March 2014 ‐ asked for raw BMI and SD values at 6 months' follow‐up 15 May 2014 ‐ asked for further details about the trial including blinding and adverse events |
20 January 2014 ‐ author replied with confirmation the data of the trial was correct and attached an addition paper for the trial 25 March 2014 ‐ author provided the raw data at 6 months 15 May 2014 ‐ provided further details on blinding 3 June 2014 ‐ gave additional results on adverse events |
Clarson 2009 | 24 January 2014 15 May 2014 |
31 January 2014 19 May 2014 |
24 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details about the trial including allocation concealment, blinding and adverse events |
31 January 2014 ‐ author confirmed there was no further data for the trial and provided a protocol for an ongoing trial 19 May 2014 ‐ author provided further details about the trial |
Franco 2014 | 24 February 2015 | 9 March 2015 | 24 February 2015 | 9 March 2015 ‐ authors replied with further details on the trial such as funding source, randomisation method and blinding |
Freemark 2001 | 20 January 2014 25 March 2014 15 May 2014 |
16 May 2014 | 20 January 2014 ‐ asked for additional unpublished data and other ongoing trials 25 March 2014 ‐ asked for BMI raw data and associated SDs 15 May 2014 ‐ asked for further details about the trial including allocation concealment, blinding and adverse events |
16 May 2014 ‐ author provided further details about the trial |
Garcia‐Morales 2006 | 21 January 2014 15 May 2014 |
No | 21 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details about the trial including the run‐in period, blinding and adverse events |
N/A |
Godoy‐Matos 2005 | 20 January 2014 15 April 2014 |
17 May 2014 | 20 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 April 2014 ‐ asked for further details about the trial including allocation concealment, randomisation method, blinding and adverse events |
17 May 2014 ‐ author provided further details about the trial |
Kendall 2013 | 24 January 2014 15 May 2014 |
29 January 2014 | 24 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details about the trial including blinding and adverse events |
29 January 2014 ‐ author confirmed no additional data were available for the trial Author did not reply to the follow‐up email (15 May 2014) |
Maahs 2006 | 20 January 2014 09 May 2014 15 May 2014 |
20 January 2014 09 May 2014 15 May 2014 |
20 January 2014 ‐ asked for additional unpublished data and other ongoing trials 09 May 2014 ‐ asked to confirmed if the data presented were SDs or SEs 15 May 2014 ‐ asked for further details on the trial's adverse events |
20 January 2014 ‐ author confirmed no further data were available for the trial 09 May 2014 ‐ author confirmed the data were SDs 15 May 2014 ‐ author could not provide further information on the adverse events |
Mauras 2012 | 24 January 2014 15 May 2014 16 May 2014 |
15 May 2014 27 May 2014 |
24 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details on the trial including allocation concealment, randomisation method, number of trial centres, blinding and adverse events 16 May 2014 ‐ asked for further information on adverse events |
15 May 2014 ‐ author provided further details on the trial 27 May 2014 ‐ author said she would try to obtain the data; however, we received no further emails |
NCT00001723 | 30 October 2015 | 30 October 2015 | 30 October 2015 ‐ asked for further details on the trial: blinding, allocation concealment, randomisation process, funding, publications and lifestyle programme | 30 October 2015 ‐ author replied and gave further details |
Ozkan 2004 | No ‐ was unable to send emails to the address given in the publication | N/A | N/A | N/A |
Prado 2012 | 17 January 2014 24 January 2014 15 May 2014 |
28 January 2014 18 May 2014 |
17 January 2014 ‐ asked for raw BMI data 24 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details on the trial including blinding, allocation concealment and adverse events |
28 January 2014 ‐ author was unable to provide any unpublished data 18 May 2014 ‐ author provided further information about the trial |
Rezvanian 2010 | 24 January 2014 15 May 2014 |
24 January 2014 15 May 2014 |
24 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details on the trial including allocation concealment and adverse events |
24 January 2014 ‐ author confirmed there were no further details to give on the trial and provided references to other potentially relevant trials 15 May 2014 ‐ author provided further details about the trial |
Srinivasan 2006 | 20 January 2014 15 May 2014 |
15 May 2014 | 20 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details on the trial including allocation concealment and adverse events |
15 May 2014 ‐ author provided further details about the trial |
Van Mil 2007 | 20 January 2014 15 May 2014 |
20 January 2014 30 May 2014 |
20 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details on the trial including randomisation, blinding and adverse events |
20 January 2014 ‐ author confirmed findings were correct and highlighted the main finding of their trial 30 May 2014 ‐ author provided further details about the trial |
Wiegand 2010 | 24 January 2014 15/04/2014 |
27 January 2014 | 24 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details on the trial including allocation concealment, randomisation, blinding and adverse events |
27 January 2014 ‐ author confirmed there was no further data available for the trial Author did not reply to the follow‐up email |
Wilson 2010 | 24 January 2014 15 May 2014 |
24 January 2014 15 May 2014 |
24 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details on the trial including dropouts and adverse events |
24 January 2014 ‐ author confirmed there was no unpublished data on the main outcomes of the trial 15 May 2014 ‐ author said he would try to obtain the data; however, I did not receive any further emails |
Yanovski 2011 | 24 January 2014 15 May 2014 |
24 January 2014 | 24 January 2014 ‐ asked for additional unpublished data and other ongoing trials 15 May 2014 ‐ asked for further details on the trial's adverse events |
24 January 2014 ‐ author confirmed the trial was over and there is no further information available Author did not reply to the follow‐up email |
BMI: body mass index; N/A: not applicable; SD: standard deviation; SE: standard error. |